News

GLP-1 receptor agonists may increase incidence of diabetic retinopathy while reducing its complications

For individuals with type 2 diabetes (T2D), glucagon-like peptide 1 receptor agonist (GLP-1 RA) use is associated with a ...
News-Medical.Net on MSN2h

Study supports pre-surgery use of GLP-1 RAs for weight reduction

Overweight patients waiting for operations could safely use a particular type of weight-loss treatment to reduce the risk of ...
ScienceAlert on MSN19h

Scientists May Have Identified a Natural Alternative to Ozempic

Glucagon-like peptide-1 (GLP-1) is a hormone that is naturally produced by the body and which helps regulate blood sugar ...
HealthDay on MSN14h

GLP-1 Receptor Agonists May Reduce Complications of Diabetic Retinopathy

For individuals with type 2 diabetes (T2D), glucagon-like peptide 1 receptor agonist (GLP-1 RA) use is associated with a ...

Obese surgical patients can safely use GLP-1 therapy to reduce risk of complications, study concludes

Overweight patients waiting for operations could safely use a particular type of weight-loss treatment to reduce the risk of ...

GLP-1 microdosing for weight loss: Experts weigh the pros and cons

One popular health platforms is promoting GLP-1 microdosing for weight loss: But how safe and effective is this approach?
TCTMD5d

Oral GLP-1 Drug Yields 12% Weight Loss in Nondiabetic Patients With Obesity

ATTAIN-1 is the second trial this year to show positive results with once-daily orforglipron, with best results seen at the ...
Science Daily4d

What really happens to your body when you stop weight loss drugs like Ozempic

Stopping prescription weight loss drugs often leads to significant weight regain, according to a large-scale analysis of 11 ...
News-Medical.Net on MSN1d

Brain’s energy control map offers blueprint for next-gen weight loss therapies

Scientists map how the brain integrates hormonal and neural signals from the body to control appetite, energy use, and reward ...

GLP-1 "Arms Race" Broadens to Include Dozens of Companies

Lexaria highlights DehydraTECH's adverse events improvement opportunity KELOWNA, BC / ACCESS Newswire / August 6, 2025 / ...
Mirage News1d

GLP-1 Receptor Agonists Linked to Vision Risks in Diabetes

In this cohort study of individuals with type 2 diabetes (T2D), glucagon-like peptide-1 receptor agonist (GLP-1 RA) use was ...
EurekAlert!2d

GLP-1 receptor agonists and sight-threatening ophthalmic complications in patients with type 2 diabetes

In this cohort study of individuals with type 2 diabetes (T2D), glucagon-like peptide-1 receptor agonist (GLP-1 RA) use was associated with a modestly increased risk of incident diabetic retinopathy ...